1.
Gan WL, Mustafar R, Kamaruzaman L, Mohd R, Cader RA, Kong WY, Pau KB. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis. Acta Med Indones [Internet]. 2018Oct.16 [cited 2026May2];50(3):237. Available from: https://www.actamedindones.org/index.php/ijim/article/view/790